Research update DanCann

Research update, DanCann Pharma Q2 2021: Transformative acquisition adds great value

12 Oct 2021

Read the full report here:

Update DanCann Pharma October 12, 2021


DanCann continues to execute on its laid-out growth strategy. An important milestone is the significant progress in the clinical development of its partner Tetra Biopharma for the company’s product candidate QIXLEEF™. A strengthened cash position also sets the stage for continued strong business activity. A strategic acquisition that moves the company’s growth strategy forward 6-12 months is, in our view, transformative for the company. We raise our view on the fair value per share to DKK 8.5 (7.0) for the next 6-12 months. This is in light of the value-adding acquisition of CannGros.

A Nordic player in medical cannabis

DanCann was founded in 2018 by the current CEO. Jeppe Krog Rasmussen. The company’s strategy is to provide medical cannabis to the European market. It intends to do this by (i) importing and distributing medical cannabis products, (ii) cultivating and exporting cannabis raw material, and (iii) identifying and developing cannabis products as part of combination medicines. The outlined strategy allows for several potential revenue streams.

Strengthened cash position gives breathing space

DanCann is an early-stage company with no reported revenues. In line with our forecasts. No revenues were announced in the second quarter. The EBITDA result amounted to DKK -3.6 million. Cash flow totalled at DKK -6.9 million and is, as in the first quarter, to a large extent attributed to investments in BIOTECH PHARM1.

At the end of the second quarter, the company had cash of DKK 5.8 million. As we mentioned in the previous updates, future capital needs are imminent and could be seen as a proximate risk. We are therefore pleased that DanCann has strengthened its cash position through directed issues combined with loans. Together, these activities give yielded new cash of DKK 16.3 million. The improved cash position provides the company with room to execute its growth strategy, at least in the short term.

Acquisition of CannGros, a market-leading distributor

As in previous analyses, our sales forecast is risk-adjusted with probabilities. In light of progress in manufacturing, we choose to revise the risk adjustment for sales of raw material to a probability of 48 per cent (from earlier 40 per cent). We have consolidated the expected revenues and costs from CannGros. Likewise, we revise the risk-adjusted revenue from the distribution business to a probability of 48 per cent (40). That results in higher expected revenues over the forecast period. We also model with slightly lower investments in H2 compared to H1. That increase the fair value of DanCann. However, weak performance in the sector results in a fall of the peer valuation by close to 40 per cent. Net, we calculate a fair value of DKK 8.5 (7.0) per share for the next 6-12 months.

Significant potential upside to fair value

As in previous analyses, our sales forecast is risk-adjusted with probabilities. In light of progress in manufacturing, we choose to revise the risk adjustment for sales of raw material to a probability of 48 per cent (from earlier 40 per cent). We have consolidated the expected revenues and costs from CannGros. Likewise, we revise the risk-adjusted revenue from the distribution business to a probability of 48 per cent (40). That results in higher expected revenues over the forecast period. We also model with slightly lower investments in H2 compared to H1. That increase the fair value of DanCann. However, weak performance in the sector results in a fall of the peer valuation by close to 40 per cent. Net, we calculate a fair value of DKK 8.5 (7.0) per share for the next 6-12 months.


Disclaimer

Carlsquare AB, www.carlsquare.se, hereinafter referred to as Carlsquare, conducts business with regard to Corporate Finance and Equity Research in which areas it, among other things, publishes information about companies including analyses. The information has been compiled from sources that Carlsquare considers to be reliable. However, Carlsquare cannot guarantee the accuracy of the information. Nothing written in the analysis should be regarded as a recommendation or invitation to invest in any financial instrument, option or the like. Opinions and conclusions expressed in the analysis are intended only for the recipient.

The content may not be copied, reproduced or distributed to another person without the written approval of Carlsquare. Carlsquare shall not be held responsible for any direct or indirect damage caused by decisions made on the basis of information contained in this analysis. Investments in financial instruments provide opportunities for value increases and profits. All such investments are also subject to risks. Risks vary between different types of financial instruments and combinations of these. Historical returns should not be considered as an indication of future returns.

The analysis is not directed to U.S. persons (as defined in Regulation S of the United States Securities Act and interpreted in the United States Investment Company Act 1940) nor may it be disseminated to such persons. The analysis is also not directed to such natural and legal persons where the distribution of the analysis to such persons would result in or entail a risk of a violation of Swedish or foreign law or constitution.

The analysis is a so-called Commissioned Research Report where the analysed Company has signed an agreement with Carlsquare for analysis coverage. The analyses are published on an ongoing basis during the contract period and for a usual fixed remuneration.

Carlsquare may or may not have a financial interest in the subject of this analysis. Carlsquare values the assurance of objectivity and independence and has established procedures for managing conflicts of interest for this purpose.

The analysts Jonatan Andersson, Markus Augustsson, Richard Ramanius and Ulf Boberg do not own and are not allowed to own shares in the company analysed.

Team

Picture of Jessica Algner
Jessica Algner

Assistant

Telephone: +49 30 809 33 47-12

LinkedIn

@

Picture of Polina Amini
Polina Amini

Senior Associate

Telephone: +49 40 300 836-14

LinkedIn

@

Picture of Jonatan Andersson
Jonatan Andersson

Equity Analyst

Telephone: +46 70 508 00 51

LinkedIn

@

Picture of Markus Augustsson
Markus Augustsson

Head of Equity Research

Telephone: +46 76 235 03 20

LinkedIn

@

Picture of Agata Barsallo
Agata Barsallo

Office Management & Accounting

Telephone: +44 20 8017 6020

@

Picture of Caroline Berglund
Caroline Berglund

Head of Equity Sales

Telephone: +46 73 382 10 82

LinkedIn

@

Picture of Anders Bo
Anders Bo

Managing Partner

Telephone: +45 4199 8252

LinkedIn

@

Picture of Ulf Boberg
Ulf Boberg

Senior Advisor Life Sciences

Telephone: +46 73 312 44 90

LinkedIn

@

Picture of Manfred Drax
Manfred Drax

Partner

Telephone: +49 89 255 49 53-15

LinkedIn

@

Picture of Anders Elgemyr
Anders Elgemyr

Managing Partner

Telephone: +46 70 496 18 15

LinkedIn

@

Picture of Niklas Elmhammer
Niklas Elmhammer

Senior Equity Analyst

Telephone: +46 898 39 59

LinkedIn

@

Picture of Sebastian Fischer
Sebastian Fischer

Director

Telephone: +49 89 255 49 53-12

LinkedIn

@

Picture of Daniel Garlipp
Daniel Garlipp

Managing Partner

Telephone: +49 40 300 836-19

LinkedIn

@

Picture of Philip Goldhahn
Philip Goldhahn

Vice President

Telephone: +49 40 300 836-21

LinkedIn

@

Picture of Thorsten Grandt
Thorsten Grandt

Vice President

Telephone: +49 30 809 33 47-20

LinkedIn

@

Picture of Johan Heigard
Johan Heigard

Vice President

Telephone: +46 70 246 99 88

LinkedIn

@

Picture of Caroline Heintz
Caroline Heintz

Senior Associate

Telephone: +46 707 40 68 58

@

Picture of Maurice Hinrichs
Maurice Hinrichs

Associate

Telephone: +49 40 300 836-20

LinkedIn

@

Picture of Arnold Holle
Arnold Holle

Managing Partner

Telephone: +44 20 80176020

LinkedIn

@

Picture of Lars Johansen
Lars Johansen

IT&Telecom Expert

@

Picture of Elaine Kelly
Elaine Kelly

Head of Marketing

Telephone: +49 40 300 836 18

LinkedIn

@

Picture of Anna-Lena Kickbusch
Anna-Lena Kickbusch

Office Management & Accounting

Telephone: +49 40 300 836 10

LinkedIn

@

Picture of Morten Kjærulff
Morten Kjærulff

Partner

Telephone: +45 2634 9031

LinkedIn

@

Picture of Mischa Krause
Mischa Krause

Director

Telephone: +49 40 300 836-24

LinkedIn

@

Picture of Steffen Leckert
Steffen Leckert

Managing Partner

Telephone: +49 89 255 49 53 26

LinkedIn

@

Picture of Malve Liebig
Malve Liebig

Senior Associate

Telephone: +49 89 255 49 53-18

LinkedIn

@

Picture of Erik Lundberg
Erik Lundberg

Partner

Telephone: +46 73 850 35 59

LinkedIn

@

Picture of Eva Macha
Eva Macha

Office Management & PA to Michael Moritz

Telephone: +49 30 809 33 47-10

LinkedIn

@

Picture of Mandy May
Mandy May

Head of Operations

Telephone: +49 30 809 33 47 16

LinkedIn

@

Picture of Mirja Meyer
Mirja Meyer

Office Management & Accounting

Telephone: +49 40 300 836 10

@

Picture of Mark Miller
Mark Miller

Managing Partner

Telephone: +49 40 300 836-11

LinkedInXING

@

Picture of Michael Moritz
Michael Moritz

Managing Partner

Telephone: +49 30 809 33 47-13

LinkedIn

@

Picture of Bertil Nilsson
Bertil Nilsson

Senior Equity Analyst

Telephone: +46 70 434 90 03

LinkedIn

@

Picture of Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telephone: +45 4199 8251

LinkedIn

@

Picture of Anika Schaefer
Anika Schaefer

Office Management & HR

Telephone: +49 89 255 495 310

@

Picture of Alexander Schleppegrel
Alexander Schleppegrel

Associate

Telephone: +45 2621 0543

LinkedIn

@

Picture of Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Managing Partner

Telephone: +49 89 255 49 53-17

@

Picture of Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telephone: +49 89 255 49 53-11

LinkedIn

@

Picture of Jon Tingling
Jon Tingling

Vice President

Telephone: +44 77 1347-8286

LinkedIn

@

Picture of Sybille de Vegvar
Sybille de Vegvar

Business Development & Marketing

Telephone: +44 20 8017 6017

@

Picture of Oskar Wollert
Oskar Wollert

Vice President

Telephone: +46 761 71 11 60

@

Picture of Jan-Frederik Zapp
Jan-Frederik Zapp

Associate

Telephone: +49 30 8093347-31

LinkedIn

@

Picture of Nils Zettelmeyer
Nils Zettelmeyer

Director

Telephone: +49 30 809 33 47-25

LinkedIn

@

Picture of Andreas Zetzsche
Andreas Zetzsche

Partner

Telephone: +49 30 809 3347 33

@

Picture of Marta Zientarski
Marta Zientarski

Vice President

Telephone: +46 73 840 55 66

@